Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses
Treatment of influenza A viruses with broadly neutralizing monoclonal antibodies is an area of active research. Here, the authors characterise a human monoclonal antibody called 3E1 that was reactive against both H1 and H5 viruses in vitroand demonstrated some treatment efficacy in mice.
Guardado en:
Autores principales: | Wenshuai Wang, Xiaoyu Sun, Yanbing Li, Jinpeng Su, Zhiyang Ling, Tianlong Zhang, Fang Wang, Hong Zhang, Hualan Chen, Jianping Ding, Bing Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/133592a173724d4893bab2f4f11b4436 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phylogenetic and pathogenic analyses of avian influenza A H5N1 viruses isolated from poultry in Vietnam.
por: Dongming Zhao, et al.
Publicado: (2012) -
H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines
por: Sook-San Wong, et al.
Publicado: (2017) -
Treatment and Prevention of Pandemic H1N1 Influenza
por: Suresh Rewar, et al.
Publicado: (2016) -
The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
por: Cuiling Xu, et al.
Publicado: (2011) -
Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response
por: Anders Madsen, et al.
Publicado: (2021)